1. NAFLD and type 2 diabetes: A practical guide for the joint management.
- Author
-
Genua I, Iruzubieta P, Rodríguez-Duque JC, Pérez A, and Crespo J
- Subjects
- Humans, Obesity complications, Non-alcoholic Fatty Liver Disease complications, Non-alcoholic Fatty Liver Disease therapy, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 therapy
- Abstract
Non-alcoholic fatty liver disease (NAFLD) is becoming a major cause of liver disease-related morbidity, as well as mortality. Importantly, NAFLD is considered a mediator of systemic diseases including cardiovascular disease. Its prevalence is expected to increase, mainly due to its close association with obesity and type 2 diabetes mellitus (T2D). In addition, T2D and NAFLD share common pathophysiological mechanisms, and one can lead to or worsen the other. Therefore, a close collaboration between primary care physician, endocrinologists and hepatologists is essential to optimize the management of patients with NAFLD and T2D. Here, we summarize relevant aspects about NAFLD and T2D that all clinician managing these patients should know as well as current therapeutic options for the treatment of T2D associated with NAFLD., (Copyright © 2022 Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF